Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of BMI on Median Effective Dose (ED50) of Intrathecal Hyperbaric Bupivacaine for Total Knee Replacement Arthroplasty

NCT01291186 is registered in ClinicalTrials.gov with Seoul Medical Center as lead sponsor.

NCT NCT01291186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01291186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of BMI on Median Effective Dose (ED50) of Intrathecal Hyperbaric Bupivacaine for Total Knee Replacement Arthroplasty
Lead sponsor
Seoul Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2010
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, knee